TriPcides target MRSA, suppress infection and kill dormant bacteria to open a new front against antibiotic resistance
In a new study, researchers show how so‑called TriPcides can target the bacterium Staphylococcus aureus, including antibiotic‑resistant strains such as MRSA. The compounds disrupt the bacteria's ability to cause infection ...